Sunlight Pharmaceuticals Private Limited
About Sunlight Pharmaceuticals Private Limited
Data last updated:
Sunlight Pharmaceuticals Private Limited is a private limited company based in Gorakhpur, Uttar Pradesh, India. It operates in the wholesale distribution segment of the trading and commerce sector. It was incorporated on 29 June 2011 and has been in existence for over 15 years.
The company is registered with the Registrar of Companies (ROC), Kanpur, under CIN U51101UP2011PTC045501. Its GSTIN is 09AAQCS0812D1ZG (Uttar Pradesh).
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Raja Israrali Rizvi and Afreen Bano.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at House No 81 Near Shifa Hospital Purana Gorakhpur Gorakhnath, Uttar Pradesh, India – 273015.
As per the financials filed for FY 2025, the company reported a revenue of ₹11.45 Lakh, a decline of 2% compared to the previous year. For the same year it recorded a net loss of ₹10,662 (net margin -0.9%) and EBITDA of -₹10,662 (EBITDA margin -0.9%). Revenue has grown at a compounded annual rate (CAGR) of 16% over three years and 3% over five years.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Contact details
Sunlight Pharmaceuticals Private Limited's registered office is in Gorakhpur, Uttar Pradesh. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressHouse No 81 Near Shifa Hospital Purana Gorakhpur Gorakhnath, Uttar Pradesh, India – 273015
- IndustryTrading, Other Wholesale, Wholesale
To see the full contact details of Sunlight Pharmaceuticals Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Sunlight Pharmaceuticals is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Sunlight Pharmaceuticals Private Limited, buy the company report.
Financials of Sunlight Pharmaceuticals Private Limited
FY 2025 filings availableSunlight Pharmaceuticals Private Limited reported revenue of ₹11.45 Lakh (down 2% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue fell 2% in the latest year, but over five years it has grown at a compounded annual rate (CAGR) of 3%. EBITDA rose 1% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | -₹10,662 | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | -₹10,662 | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | -0.9% | ||||
| Net Profit Margin | -0.9% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Sunlight Pharmaceuticals Private Limited, buy the company report.
Board of directors of Sunlight Pharmaceuticals Private Limited
Sunlight Pharmaceuticals has 2 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Raja Israrali Rizvi | Director | 29 Jun 2011 | 15 Years 4 Months | Current |
| Afreen Bano | Director | 29 Jun 2011 | 15 Years 4 Months | Current |
Peer comparison
Sunlight Pharmaceuticals Private Limited is compared with the 6 companies closest to it by revenue in the Pharma industry (Pharmaceuticals), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Healthsys Pharmaceuticals Private Limited | ₹11.54 Lakh (FY 2023) | 31.0% | Pune, Maharashtra, India | |||
| Manfred Pharmaceuticals Private Limited | ₹11.51 Lakh (FY 2025) | 24.0% | Kolhapur, Maharashtra, India | |||
| Country First Pharmaceuticals Private Limited | ₹11.49 Lakh (FY 2024) | 11978.0% | Agra, Uttar Pradesh, India | |||
| Eart Pharmaceuticals Private Limited | ₹11.46 Lakh (FY 2025) | -55.0% | Delhi, India | |||
| Sunlight Pharmaceuticals Private Limitedthis company | ₹11.45 Lakh (FY 2025) | -₹10,662 | -0.9% | -2.0% | Gorakhpur, Uttar Pradesh, India | |
| Curador Pharmaceuticals Private Limited | ₹11.45 Lakh (FY 2025) | -35.0% | Ghaziabad, Uttar Pradesh, India | |||
| Sybella Pharmaceuticals Private Limited | ₹11.37 Lakh (FY 2025) | 22.0% | Mumbai, Maharashtra, India |
To see the full peer comparison of Sunlight Pharmaceuticals Private Limited, buy the company report.
Shareholding
The shareholding of Sunlight Pharmaceuticals Private Limited is on record for FY 2016, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2016 |
|---|---|
| Promoters | |
| Domestic institutional investors (DII) | |
| Foreign institutional investors (FII) | |
| Public | |
| Others |
To see the full shareholding pattern of Sunlight Pharmaceuticals Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Sunlight Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Sunlight Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Sunlight Pharmaceuticals has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 09AAQCS0812D1ZG | Uttar Pradesh | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Sunlight Pharmaceuticals Private Limited, buy the company report.
Recent activity
Sunlight Pharmaceuticals Private Limited has 2 board changes on record since 2011: 2 appointments. The latest: Afreen Bano was appointed as Director on 29 Jun 2011.
Frequently asked questions
Sunlight Pharmaceuticals is an active private limited company based in Gorakhpur, Uttar Pradesh, India. The company works in other wholesale, within the trading industry. It was incorporated on 29 June 2011 (15+ years old) and is registered under CIN U51101UP2011PTC045501.
Sunlight Pharmaceuticals has 2 current directors:
- Raja Israrali Rizvi - Director
- Afreen Bano - Director
The latest financial statements of Sunlight Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Sunlight Pharmaceuticals is 09AAQCS0812D1ZG, registered in Uttar Pradesh.
The CIN (Corporate Identification Number) of Sunlight Pharmaceuticals is U51101UP2011PTC045501. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Sunlight Pharmaceuticals was incorporated on 29 June 2011, making it 15+ years old. It is registered with the Registrar of Companies, Kanpur.
The peers of Sunlight Pharmaceuticals by revenue are Healthsys Pharmaceuticals Private Limited, Manfred Pharmaceuticals Private Limited, Country First Pharmaceuticals Private Limited, Eart Pharmaceuticals Private Limited, Curador Pharmaceuticals Private Limited and 1 more, all in the Pharma industry (Pharmaceuticals), with the same principal business activity (wholesale trading).
Afreen Bano was appointed as Director on 29 Jun 2011. Raja Israrali Rizvi was appointed as Director on 29 Jun 2011.
The registered office of Sunlight Pharmaceuticals is at House No 81 Near Shifa Hospital Purana Gorakhpur Gorakhnath, Uttar Pradesh, India – 273015.
Sunlight Pharmaceuticals operates in the trading industry, in the other wholesale segment.
The compliance status of Sunlight Pharmaceuticals is compliant as of 25 July 2026. The company is actively filing with the Registrar of Companies.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
